Demographic characteristics and disease history
| Placebo (n = 10) | Dysport (n = 10) | |
|---|---|---|
| *Values are mean (SD). | ||
| †One female patient with childbearing potential in the placebo group and two in the Dysport group. | ||
| Age (y)* | 55.2 (8.3) | 53.0 (4.6) |
| Sex (n (%)) | ||
| Female† | 2 (20%) | 3 (30%) |
| Male | 8 (80%) | 7 (70%) |
| Aetiology | ||
| Central stroke (n/N (%)) | 10/10 (100%) | 10/10 (100%) |
| Haemorrhage (n/N (%)) | 6/10 (60%) | 3/10 (30%) |
| Capsulothalamic (n/N) | 5/6 | 2/3 |
| Cortical/subcortical (n/N) | 1/6 | 1/3 |
| Ischaemia (n/N (%)) | 4/10 (40%) | 7/10 (70%) |
| Middle cerebral artery (n/N) | 4/4 | 7/7 |
| Anterior cerebral artery (n/N) | 0/4 | 1/7 |
| Location of cerebral lesion (n/N (%)) | ||
| Right side | 6/10 (60%) | 4/10 (40%) |
| Left side | 4/10 (40%) | 6/10 (60%) |
| Time between lesion and Dysport treatment (days)* | 794 (1050) | 224 (187) |